GE HealthCare imaging CEO steps down amid mixed earnings results
GE HealthCare is combing two of its radiology-related business lines into a new segment worth $14.6 billion, the company announced Wednesday.
The imaging manufacturer will merge its imaging and advanced visualization wings into one, bringing GEHC’s two largest segments together. This will allow the Chicago-based firm to create a more “focused and connected end-to-end imaging ecosystem,” spanning diagnosis, intervention and follow-up care.
As part of the transition, GE HealthCare is appointing Phil Rackliffe, MBA, as president and CEO of Advanced Imaging Solutions. He previously served as the company’s head of advanced visualization products (2024–2026) and image guided therapies (2022–2024). Meanwhile, Roland Rott GEHC’s president and CEO of imaging since 2024, is leaving the company to “pursue external opportunities.”
The move comes as GE HealthCare announced mixed quarterly earnings results on Wednesday, forcing leaders to cut their profit outlook.
“I want to thank Roland for his significant contributions over the past 15 years,” Peter Arduini, MBA, president and CEO of GE HealthCare, said in a statement April 29. “He helped build a strong culture of innovation, collaboration and customer focus that will continue to shape the organization for years to come,” he added later.
GEHC’s Advanced Imaging Solutions division now spans MRI, CT, molecular imaging, women’s health and X-ray. The addition of advanced visualization products includes specialized ultrasound, interventional guidance technology, workstations and other technologies. In a LinkedIn post Wednesday, Rackliffe said this realignment better reflects how radiology care is delivered in 2026.
“This move is grounded in what we’re hearing from customers and seeing across healthcare,” he wrote April 29. “Imaging is no longer a set of discrete moments—it’s a connected workflow from detection through diagnosis to intervention.”
As part of the transition, GEHC is appointing Catherine Estrampes as chief commercial and growth officer for leading global markets. This new region encompasses every market except for China, which will continue to be overseen by Will Song. The company hopes this new geographic focus will help it to “strengthen how commercial teams build and scale expertise across markets” and bring the full [imaging] portfolio to customers globally.”
More on mixed earnings results
GE HealthCare also announced its 2026 first quarter earnings results on Wednesday in conjunction with the changes. The company said its profitability was impacted by a pharmaceutical diagnostics supplier recall issue that has “since been solved.” GEHC also saw significant increases in costs for memory chips, oil and freight, which are expected to impact the rest of 2026.
“Given these dynamics,” CEO Peter Arduini said, GEHC is reducing its profit outlook. He said the company hopes to offset more than half of the inflation impact with price increases and cost cutting.
“Importantly, we are making meaningful progress executing on our new wave of innovation to accelerate future revenue and margin growth,” he said in a statement.
Overall, total Q1 sales for GE HealthCare were up about 7% year over year including organic revenue growth of almost 3%, climbing to $5.1 billion. GEHC’s stock price dropped nearly 13% in morning trading following news of the challenges.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.